DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Home > Aktien > Quidel Aktie > Nachrichten zu Quidel

Quidel Aktie [WKN: 867261 / ISIN: US74838J1016]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Quidel Corp.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Quidel Corp.

23.02.10Diagnostic Hybrids Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
19.02.10Quidel Corporation Completes Acquisition of Diagnostic Hybrids
11.02.10Quidel Reports Fourth Quarter and Full Year 2009 Results
29.01.10Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010
11.01.10Quidel Corporation Announces Definitive Agreement to Acquire Diagnostic Hybrids
04.01.10Quidel Corporation to Present at the 28th Annual J.P. Morgan Healthcare Conference
08.12.09Quidel Authorizes Additional $25 Million under Stock Repurchase Program
16.10.09Quidel Reports Third Quarter 2009 Results
16.10.09Quidel Announces Launch of Their MicroVue® C5a EIA Kit for Research Use Only
06.10.09Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation
22.09.09Quidel to Present at the William Blair & Company Emerging Growth Stock Conference
18.09.09Quidel Issues Clarification Regarding Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert
17.09.09Quidel Obtains Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert
10.09.09Quidel Anticipates Record Quarterly Results Driven by Strong Demand for Flu Tests
10.09.09Quidel to Present at Investor Conferences in September
10.08.09Quidel Launches Flu Test Educational Programs for the Clinical Community
06.08.09Quidel Announces Executive Appointments
06.08.09Quidel Announces Executive Appointments
22.07.09Quidel Reports Second Quarter 2009 Results
09.07.09Quidel to Hold 2009 Second Quarter Conference Call on July 22, 2009
10.06.09Quidel Corporation to Attend the Sixth Annual Craig-Hallum Institutional Investor Conference
22.04.09Quidel Reports First Quarter 2009 Results
08.04.09Quidel to Hold 2009 First Quarter Conference Call on April 22, 2009
31.03.09Quidel Announces Strategic Restructuring and Work Force Reduction
16.03.09Quidel Provides Update on Impact of Current Influenza Season and Macroeconomic Trends
13.03.09Quidel Schedules Conference Call for March 16, 2009 to Provide Business Update
25.02.09Quidel Reports Fourth Quarter and Full Year 2008 Results
18.02.09Quidel Corporation Webinar Addresses Management of Influenza in Long-Term Care Facilities
10.02.09Quidel to Hold 2008 Fourth Quarter and Year-End Financial Results Conference Call on February 25, 2009
22.01.09Flu Has Arrived in Dallas-Fort Worth Per the FluSTAR Flu Tracking and Reporting System1 and Local Public Health
20.01.09Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer
19.01.09Quidel Launches rsvtesting.com; Web Site Delivers Practical Information on Respiratory Syncytial Virus (RSV)
06.01.09Quidel Corporation to Present at the 27th Annual J.P. Morgan Healthcare Conference
05.01.09Caren L. Mason, President & CEO, to Retire from Quidel in 2009
09.12.08Quidel’s QuickVue® iFOB Test Results Show High Correlation with Quantitative Laboratory Assay for Fecal Occult Blood Using Stools from Patients with Post-Colonoscopy Based Clinical Diagnosis
02.12.08Quidel Authorizes Additional $25 Million under Stock Repurchase Program
01.12.08Quidel to Present at the 20th Annual Piper Jaffray Healthcare Conference
07.11.08Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs
22.10.08Quidel Reports Third Quarter 2008 Results
09.10.08Quidel Corporation Secures New $120 Million Credit Facility

Anzeige

ANZEIGE

Seite: 12
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon